ImmunityBio, Inc. IBRX Issuances of common stock from employee benefit plans receivable
Issuances of common stock from employee benefit plans receivable at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConversionOfStockAmountIssued1.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s issuances of common stock from employee benefit plans receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s issuances of common stock from employee benefit plans receivable?
- ImmunityBio, Inc. (IBRX) reported issuances of common stock from employee benefit plans receivable of $35.33M in Q1 2026.